Neurolin is a growth-associated cell surface glycoprotein from goldÐsh and zebra Ðsh which has been shown to be involved in axonal path-Ðnding in the goldÐsh retina and suggested to function as a receptor for axon guidance molecules. Being a member of the immunoglobulin superfamily of cell adhesion proteins, neurolin consists of Ðve N-terminal extracellular immunoglobulin (Ig)-like domains, a transmembrane and a short cytoplasmatic domain. Repeated injections of polyclonal Fab fragments against neurolin and of monoclonal antibodies against either Ig domains cause path-Ðnding errors and disturbance of axonal fasciculation. In order to obtain a complete structural characterization and a molecular basis for structure-function determination, recombinant neurolin with the complete extracellular part but lacking the transmembrane and cytoplasmatic domain was expressed in Chinese hamster ovary (CHO) cells (CHO-neurolin). The isolation of CHO-neurolin was carried out by Ni-affinity chromatography and subsequent high-performance liquid chromatography (HPLC). An exact molecular mass determination was obtained by matrix-assisted laser desorption/ionization mass spectrometry (MALDI/MS) and revealed 60.9 kDa, which suggested that ¿10 kDa are due to glycosylation. The predicted molecular mass is 51.5 kDa, whereas sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) yielded an apparent molecular mass of 72 kDa. Gel shift assays using SDS-PAGE and Western blot analysis with anti-neurolin antibodies provided consistent molecular mass data. The complete primary structure and N-glycosylation patterns were identiÐed using speciÐc lectin assays, MALDI/MS peptide mapping analysis by proteolytic and in-gel digestion, electrospray ionization MS and MALDI/MS in combination with speciÐc glycosidase degradation. HPLC isolation of glycosylated peptide fragments and MS after selective deglycosylation revealed heterogeneous glycosylations at all Ðve N-glycosylation consensus sites. All attached N-glycans are of the complex type and show a mainly biantennary structure ; they are fucosylated with a(2,3)-terminal neuraminic acid. These data serve as a Ðrst detailed model to characterize the molecular recognition structures exhibited by the extracellular domains.
INTRODUCTION
During nervous system development, axons are guided to their targets by cues in their environment and express on their surface recognition/receptor components. have been identiÐed in the goldÐsh and zebra Ðsh central nervous system (CNS), where they are reexpressed during axon regeneration in the adult CNS.2,3 Cell adhesion proteins (CAMs) of the immunoglobulin (Ig) superfamily play a prominent role in the axon path-Ðnding2,4h7 and can function as axonal surface receptors for guidance cues. 2 The neuronal cell adhesion protein neurolin has been identiÐed as an integral membrane protein and a member of the Ig superfamily4,6,8 with the characteristic Ig extracellular domain structure and a single transmembrane and short C-terminal cytoplasmatic sequence (Fig. 1) .9,10 Neurolin is the homologue of mammalian and avian DM-GRASP/SC-1/BEN, expressed in growing retinal ganglion cell axons of the goldÐsh, and has been shown to be involved in axonal path-Ðnding. 5, 10 The N-terminal, extracellular part consists of Ðve Ig-loop domains4, 6, 8 in which all Ðve potential N-glycosylation sites are located (Fig. 1) . Native goldÐsh neurolin has been shown to be a glycoprotein. 10 Its predicted molecular mass from the amino acid sequence is 57 832 Da. The apparent molecular mass determined by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is D86 kDa, suggesting that the protein is extensively glycosylated.10 However, despite the biochemical signiÐcance of glycosylation,11 and other post-transitional modiÐcations for cellular recognition and interaction, only a few structural details for cell adhesion proteins have so far been determined. 8,12h14 The primary structure of native neurolin immunopuriÐed from goldÐsh brain has been characterized in a recent study,9 chieÑy by mass spectrometric (MS) peptide mapping of tryptic peptides using matrixassisted laser desorption/ionization (MALDI). For this native protein, however, no glycosylated peptides were detected by MS peptide mapping, although the complete sequence could be identiÐed and indirect evidence was obtained for a heterogeneous and/or partially truncated N-glycosylation. 10 The usefulness of both MALDI/MS15h18 and electrospray ionization (ESI) MS19,20 for the characterization of glycosylated peptides and proteins has recently been demonstrated and several MS approaches successfully employed for the identiÐcation of post-translational modiÐcations and even higher order structures in proteins.
In the present study, recombinant neurolin, encompassing the complete extracellular domain (including potential modiÐcations, see Fig. 1 ), was expressed in Chinese hamster ovary cells (CHO ; CHO-neurolin) and puriÐed by Ni-affinity chromatography utilising a Cterminal oligo-His-tag sequence (see Fig. 4 ). The extracellular disulphide-loop pattern of CHO-neurolin was ascertained by MS disulphide mapping.12 Disulphidelinked peptides were deglycosylated with PNGase F and analysed by MALDI/MS before and after selective reduction with dithiothreitol (DTT). MALDI/MS peptide mapping, in combination with highperformance liquid chromatography (HPLC), and mass spectrometry (MALDI/MS and ESI-MS) of isolated glycopeptides were performed before and after selective glycosidase degradation using neuramidase and PNGase F. The results revealed heterogeneous glycosylation at all Ðve potential glycosylation sites. The complete pattern of N-glycans was identiÐed to be of complex type with predominantly biantennary structures. In addition, a direct MALDI/MS analysis of the intact protein was obtained and revealed a molecular mass determination in good agreement with the sum of amino acid sequence and structural modiÐcations.
EXPERIMENTAL Recombinant expression of neurolin in CHO cells
The cDNA coding for the Ðve extracellular Ig-like domains of neurolin, including the signal and the Kozak sequences, was ampliÐed in a standard PCR with the full-length neurolin cDNA clone P19 as template and the primers 5@-AT TAGAGCTCAC CATGCAATCGGT TGTCTGC C-TTATC and 5@-CTAGTGATGGTGATGGTGATGA-AACACGCTGATCTCCTTCGTGTC. The antisense primer was extended at the 5@-end by a stop codon (TAG) and six triplets coding for the amino acid histidine (CAG and CAC, respectively) to facilitate puriÐ-cation of the protein. The PCR product (1470 bp) was directly ligated into the eukaryotic expression vector pCR3 (Invitrogen, Leek, The Netherlands) and the integrity of the construct was conÐrmed by double stranded sequencing with a T7 Sequencing Kit (Amersham Pharmacia Biotech, Freiburg, Germany).
The neurolin expression clone and the pCR3 vector without an insert (mock control) were transfected into CHO cells using calcium phosphate precipitation. Stable transfectants were selected by their resistance to geneticin (500 lg ml~1) (Gibco BRL, Eggenstein, Germany). Expression of soluble neurolin by the transfected CHO cells was conÐrmed by immuno-staining and immuno-blot experiments using polyclonal and monoclonal anti-neurolin antibodies.
PuriÐcation of CHO-neurolin
CHO cells were originally cultivated at 37 ¡C and 5%
in HamÏs F12 medium (Gibco BRL) supplemented CO 2 with 10% foetal calf serum (FCS) (Gibco BRL) and 100 U ml~1 penicillinÈstreptomycin (Gibco BRL). For the puriÐcation of the recombinant neurolin protein, transfected CHO cells were converted to serum free growth using UltraCHO medium (BioWhittaker/Serva, Heidelberg, Germany). Conditioned cell culture medium was adjusted to 0.5 M NaClÈ20 mM imidazole, pH 7.3, Ðlter sterilized and loaded on to an Ni-NTA SuperÑow column (Qiagen, Hilden, Germany). The resin was washed with 10 column volumes of 0.5 M NaCl with imidazole concentrations increasing up to 50 mM. The recombinant protein was eluted with 0.5 M NaClÈ200 mM imidazole and collected in 1 ml fractions. The appropriate fractions containing neurolin were pooled and concentrated to approximately 10-fold with 10 000 molecular mass cut-o † membranes (Amicon, Beverly, MA, USA). For mass spectrometric analysis, neurolin was further puriÐed by HPLC.
Gel electrophoresis
Standard SDS-PAGE was carried out in Laemmli bu †er using 0.5 lg aliquots of HPLC-puriÐed neurolin dissolved in sample denaturation bu †er. Gels were evaluated after 1.5 h by staining (Coomassie Brilliant Blue, silver) and destaining as described previously12 using Sigma-7B mass markers from 36 to 205 kDa. For in-gel digestion/peptide mapping, gel plugs were excised and stored at [20 ¡C for further analysis.
Lectin assays
Lectin assays of the glycosylated neurolin were carried out using a Glyco di †erentiation kit (Boehringer Mannheim, Penzberg, Germany). The kit uses glycan-speciÐc lectins conjugated to the steroid hapten digoxigenin, detected by an anti-digoxigenin antibody. PuriÐed neurolin was blotted directly on nitrocellulose membranes and incubated with the lectins Gelanthus nivalis agglutinin (GNA) Sambucus nigra agglutinin (SNA), peanut agglutinin (pna), Maackia amurensis agglutinin (MAA) and Datura stramonium agglutinin (DSA). The speciÐcity of detection was ascertained by using the following glycoproteins as controls : transferrin with Nglycans of complex type (positive for SNA), fetuin (complex N-glycans) and O-glycans (positive for SNA, MAA and DSA), asialotransferrin with O-glycans (positive for PNA) and carboxypeptidase Y with highmannose-type N-glycans (positive for GNA).
In-gel digestion and peptide mapping
Proteolytic digestion in the gel matrix after silver training was essentially performed according to a previously published procedure21 with slight modiÐcations. The excised gel plug was dehydrated in acetonitrile, the solvent was removed and the plug was rehydrated in 50 mM ammonium hydrogencarbonate solution. This procedure was repeated twice in order to remove staining agents and bu †er components. The plug was then dried under vacuum for 15 min and 0.01 lg of protease (TPCK-trypsin or Asp-N protease) in 20 ll of digestion bu †er was added. Excess protease bu †er was removed after 10 min and the plug was overlaid with the digestion bu †er, 100 ll of 50 mM All enzy-NH 4 HCO 3 . matic digests were carried out for a total of 12 h at 37 ¡C. The digestion bu †er was then removed and the mixture of proteolytic fragments extracted twice with 100 ll of aqueous acetonitrile (1 : 1, v/v, containing 0.1% triÑuoroacetic acid (TFA) for 1 h : the solution was combined with the digestion bu †er and lyophilized for MALDI/MS.
Proteolytic degradation in solution
Proteolytic digestion in solution was carried out using the endoproteinases Asp-N and Lys-C of sequencing grade (Boehringer Mannheim). TPCK-treated trypsin was obtained from Sigma (St Louis, MO, USA). All other reagents and chemicals were of analytical grade or the highest available purity. Approximately 15 lg of lyophilized neurolin was solubilized in 100 ll of 50 mM acetonitrile (pH 8.0) under nitrogen. NH 4 HCO 3 È10% An enzyme-to-substrate ratio of D1 : 50 was used for Asp-N digestion. The samples were incubated for 5 h at 37 ¡C. The unreduced peptide fragment mixture was directly separated by HPLC or subsequently reduced with dithiothreitol (DTT) (1 h at 37 ¡C, 50-fold excess over disulphde bond) and alkylated with iodacetamide (1 h at 37 ¡C, 2.2-fold excess over DTT). A sample aliquot of 5 ll was lyophilized and redissolved for MALDI/MS analysis ; the remaining sample was subjected to HPLC separation.
HPLC separation of proteolytic peptides
All HPLC separations were performed with a WatersMillipore M590/510 solvent delivery instrument equipped with an M-490 UV detector system. The peptide mixture was separated on a 25 ] 0.4 cm i.d.
Nucleosil column (Macherey-Nagel, DuisVydac-C 8 burg, Germany) using a linear binary gradient of 0.1% aqueous TFA (A) and 0.1% TFA in acetonitrile (B), from 5 to 60% B in 60 min. The HPLC fractions were lyophilized for analysis by MALDI/MS and ESI-MS. A 25 ] 0.4 cm i.d. Vydac column was employed for RP-C 4 the puriÐcation of intact neurolin (see Fig. 3 ).
Enzymatic deglycosylation
Degradations by neuraminidase and other glycosidases (Boehringer Mannheim) were performed with aliquots of the isolated peptide fraction lyophilized and redissolved in 10 mM acetonitrileÈ CH 3 COONH 4 È10% 1 mM EDTA (pH 5.0). Reactions were carried put by incubation for 48 h at 25% with an enzyme-to-substrate ratio of 1 : 50. The samples were then lyophilized and analysed by MALDI/MS. For PNgase F cleavage, an aliquot of the isolated peptide fraction was lyophilized and redissolved in 50 mM acetonitrileÈ NH 4 HCO 3 È10% 1 mM EDTA (pH 8.0) and incubated for 4 h at 37 ¡C with an enzyme-to-substrate ratio of 1 : 50. The samples were then lyophilized and analysed by MALDI/MS.
Mass spectrometry
MALDI/MS analysis was carried out with a BrukerBiÑex linear time-of-Ñight mass spectrometer equipped with a Scout source and video system, a nitrogen UV laser and a dual-channel plate detector (BrukerFranzen, Bremen, Germany). Sample preparation was generally performed by crystallization of a saturated solution using the matrix 4-hydroxy-a-cyanocinnamic acid (HCCA). Lyophilized samples were dissolved in 20 ll of acetonitrileÈwater (40 : 60) ; a 0.5 ll aliquot was mixed on the stainless-steel target with 0.5 ll of the matrix solution and the droplet was then dried at 20 ¡C. Spectra were acquired at an acceleration voltage of 20 kV, using an initial 2 kV deÑection pulse of 1È4 ls perpendicular to the ion path for removal of matrix ions ; 60È300 single laser shots were accumulated to give the spectrum. Calibration was performed with singly and doubly protonated ions of insulin as internal standard.
ESI-MS was performed with a Vestec-A201 quadrupole mass spectrometer equipped with a Vestec-ESI source and a laboratory built nano-ESI-MS source ; instrumental conditions, nano-ESI capillary and sample preparations were as described previously.13,22
RESULTS

Expression and puriÐcation of neurolin from CHO cells
The over-expressed neurolin was pre-puriÐed from the CHO cell culture medium by Ni-NTA affinity chroma- tography utilising an oligo-His-tag sequence attached to the C-terminus of the protein. With a single concentration step by ultraÐltration, the protein could be isolated from the Ni-NTA eluate by HPLC as shown in RP-C 4 Fig. 2(a) . Neurolin eluted from the HPLC column as a major fraction after 40 min, as indicated by the bracket in Fig. 2(a) . The puriÐed protein was then analysed by SDS-PAGE and identiÐed by Western blot analysis using a monoclonal anti-neurolin antibody [ Fig. 2(b) ]. SDS-PAGE revealed an apparent molecular mass of 72 kDa, suggesting that substantial glycosylation had occurred, compared with the molecular mass of 51.5 Da calculated from the amino acid sequence (see Table 1 ). The presence of protein isoforms due to heterogeneity in the glycan structure leads to an observed extended band pattern, as indicated by the small arrows in the SDS-PAGE and Western blot analysis [ Fig. 2(b) ]. The MALDI mass spectrum of the puriÐed CHO-neurolin is shown in Fig. 2(c) , revealing a molecular mass of 60.9 kDa. Compared with the calculated sequence molecular mass of 51.5 kDa (see Table 1 ), this indicated a mass proportion of D10 kDa due to glycosylation (including contributions from other post-translational modiÐcations). No single protein isoform could be resolved in the molecular ion signal. The sequence of neurolin contains Ðve potential N-glycosylation sites (see Fig. 1 ), suggesting an average modiÐcation by D2000 Da if glycosylation is assumed to be present at all consensus sites. Mass spectrometric peptide mapping was used as the initial method for the detailed analysis of the distribution and N-glycan pattern of neurolin.
Primary structure characterization of CHO-neurolin
For the initial structural analysis of neurolin, enzymatic degradation in solution and "in-gelÏ digestion were performed using the proteolytic enzymes Asp-N-protease and trypsin. MALDI/MS peptide mapping analyses of the reduced and alkylated Asp-N peptide fragments after digestion in solution are shown in Fig. 3 . The molecular ions that could be directly assigned to unmodiÐed Asp-N proteolytic peptides are indicated in the spectrum. The molecular ions at m/z 3303, 3596, 3755, 3899 and 4121 (marked by the bracket in Fig. 3 ) were identiÐed as glycosylated Asp-N peptides which were analysed in detail by selective deglycosylation, and by ESI-MS after isolation by HPLC (see below and Table 5 ). The unmodiÐed proteolytic peptides identiÐed by Asp-N digestion experiments in solution and in the gel are summarized in Table 2 , and are underlined in the neurolin sequence in Fig. 4 . No unmodiÐed peptides could be identiÐed in the sequence areas encompassing Table 5 .
the N-glycosylation consensus sites, which was in agreement with the molecular mass data and strongly corroborated the assumption that all Ðve possible sites of glycosylation in neurolin are indeed modiÐed. When compared with the Asp-N digestion in solution, the in-gel digestion with Asp-N yielded a lower sequence coverage. The tryptic peptides identiÐed by in-gel digestion are listed in Table 3 and underlined in Fig. 4 . In summary, all digestion proteolytic procedures identiÐed the amino acid sequence, the expected Nterminus after complete processing of the signal peptide and the C-terminal oligo-His tag sequence. For the analysis of the detailed N-glycan structure, the proteolytic peptide mixtures were separated by HPLC, with the main focus on the isolation and elucidation of glycopeptides. The identiÐed Asp-N glycopeptides are indicated in Fig. 4 by colours and summarized later in Table 5 .
Determination of glycosylation pattern
In order to characterize the N-glycosylation structure of neurolin in detail, gel shift assays were initially per- (Table 1) . Since only apparent molecular masses are observed by SDS-PAGE, this mass di †erence may be related to the particular modiÐed structure of neurolin. As a control, CHO-neurolin heated for 24 h at 37 ¡C did not reveal any unspeciÐc proteolytic degradation under the conditions employed (Fig. 5, lane 4) . Preliminary dot-blot lectin assays of CHO-neurolin were carried out to reveal the pattern and type of the attached glycans. The speciÐcity of the lectins used and the oligosaccharide structures/types identiÐed for CHOneurolin are summarized in Table 4 . The results revealed that terminal neuraminic acid a(2,3)-linked to galactose and galactose b(1,4)-linked to Nacetylglucosamine were recognized by the lectins MAA and DAS, which is consistent with glycan structures of complex type as shown in Scheme 1. Furthermore, these data are strongly corroborated by the very weak or lack of response to GNA, which detects any terminal mannose, as part of the structural core of complex Nglycans (see Scheme 1). Complex glycoforms presenting a monosubstituted core structure are hence present in only small amounts, probably due to the glycan heterogeneities and/or partial truncation. In contrast, any signiÐcant N-glycans of high-mannose or hybrid type should provide a similarly strong response for GNA as for MAA and DAS. No terminal a(2,6)-linked neuraminic acid was detected by the SNA assay. Furthermore, the negative response to PNA was conÐrmed throughout by the MS peptide mapping data, indicating the absence or presence of traces only of Oglycosylation in CHO-neurolin.
For the detailed analysis of structural type and distribution of N-glycans in CHO-neurolin, proteolytic Scheme 1. Terminal oligosaccharide structures in CHO-neurolin recognized by specific lectins. Glycan structures detected by the lectins MAA, DSA and GNA are marked by boxes (see Table 4 ). GNA detects a terminal mannose residue ; the other mannose residues may be substituted according to the glycan structure type. peptide mixtures were separated by HPLC and the glycopeptides were isolated. Figure 6 shows the HPLC separation of the reduced and alkylated peptide mixture after Asp-N digestion, as characterized by MALDI/MS peptide mapping analysis (Fig. 3) . The fractions, containing the glycopeptides linked at all Ðve corresponding Asn residues (Asn-70, -149, -328, -419 and -443) are assigned in the HPLC trace (Fig. 6 ). All fractions were subjected to MS analysis, then treated with neuramidase and PNGase F and re-analysed by MALDI/ MS. Glycopeptide-containing fractions and the glycosylation pattern could be identiÐed by the series of molecular ions due to oligosaccharide heterogeneities revealed by mass di †erences of 162 Da (corresponding to mannose/galactose, 146 Da (fucose), 203 Da (Nacetylglucosamine) and 292 Da (neuraminic acid). The presence of terminal neuraminic acid was in all cases established by speciÐc neuramidase digestion yielding the desialyated glycan forms. These results and additional ESI-MS analyses (data not shown) conÐrmed the correct mass assignments due to the neuraminic acid glycan structures as shown in Scheme 1, thus excluding a possible presence of two fucose units. Treatment of the glycopeptide fractions with PNGase F resulted in the complete cleavage of the N-linked glycan structures to yield the deglycosylated peptides which were identiÐed as newly formed product ions in the spectra. The MALDI/MS analyses of the heterogeneous glycan structure types at Asn-70 (HPLC fraction 11 in Fig. 6 ) and assignments to the complex type glycan structures provided by glycosidase degradation (see Scheme 2) are illustrated in Fig. 7 . Fig. 8(a) . In summary, the lectin assays and residue masses of the monosaccharide cleavage products provided the assignment of composition and glycosylation patterns Scheme 2. N -Glycosylation pattern at Asn-70 and biantennary N -glycans of complex type identified for peptide (59-81) of CHO-neurolin (see also Table 5 ).
for all Ðve glycosylation sites as summarized in Table 5 . All the data suggest that biantennary complex structure types predominate, and that all N-glycans are fucosylated with terminal galactose and neuraminic acid residues.
DISCUSSION
The primary structure and complete glycosylation pattern of recombinant neurolin expressed in CHO cells and puriÐed to molecular homogeneity by HPLC were characterized by MS molecular mass determination, MALDI/MS peptide mapping, MS analysis of HPLCisolate proteolytic peptides, enzymatic deglycosylation and detection by speciÐc lectins. Taken together, these data consistently reveal heterogeneous N-glycosylations throughout the extracellular protein domain at all Ðve consensus glycosylation sites (see Fig. 1 ). All glycosylations found are of complex type with biantennaric structures predominating as shown in Schemes 1 and 2, whereas other glycan forms should be absent or present Copyright and speciÐc characterization of multiple and heterogeneous glycosylation structures. Furthermore, these methods provide a basis for a molecular comparison of the glycosylation pattern for proteins from di †erent expression systems. Corresponding studies of di †erent cell adhesion proteins (axonin, neurolin) and speciÐc recombinant domains are currently being performed in our laboratory. 
